Xenetic Biosciences, Inc. Presents at the H.C. Wainwright 26th Annual Global Investment Conference

Xenetic Biosciences, Inc. (NASDAQ: XBIO), a biopharmaceutical company specializing in immune-oncology technologies aimed at treating difficult cancers, announced today that its Interim CEO and CFO, Jim Parslow, presented at the H.C. Wainwright 26th Annual Global Investment Conference.

The video webcast of the presentation can be accessed on the Events page in the Investors section of the Company's website and will remain available for 90 days.

R. H.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based